Case Reports in Oncology

Scope & Guideline

Unlocking Insights in Oncology

Introduction

Explore the comprehensive scope of Case Reports in Oncology through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Case Reports in Oncology in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1662-6575
PublisherKARGER
Support Open AccessYes
CountrySwitzerland
TypeJournal
Convergefrom 2010 to 2024
AbbreviationCASE REP ONCOL / Case Rep. Oncol.
Frequency3 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND

Aims and Scopes

The journal 'Case Reports in Oncology' is dedicated to publishing detailed case reports that contribute to the understanding of oncology practices, therapeutic approaches, and patient outcomes. The journal serves as a platform for the dissemination of unique and rare cancer cases, highlighting novel therapeutic strategies, emerging treatment modalities, and significant clinical observations in oncology.
  1. Case Reports of Rare Cancers:
    The journal emphasizes the importance of documenting unusual cancer presentations and rare malignancies, providing valuable insights into their clinical management and treatment.
  2. Innovative Treatment Approaches:
    It highlights case reports that explore new treatment modalities, including targeted therapies, immunotherapies, and combination regimens, showcasing their efficacy and safety in various cancer types.
  3. Multidisciplinary Perspectives:
    The journal encourages submissions that reflect a multidisciplinary approach to cancer care, integrating input from medical oncologists, surgeons, radiologists, and pathologists.
  4. Patient Outcomes and Follow-ups:
    The focus is on detailed follow-up of patients post-treatment, providing data on long-term outcomes, recurrence rates, and survival, which are crucial for improving clinical practices.
  5. Emerging Genetic and Molecular Insights:
    The journal includes case reports that delve into the genetic and molecular underpinnings of cancers, enhancing the understanding of tumor biology and potential targeted therapies.
The landscape of oncology is constantly evolving, and the journal 'Case Reports in Oncology' reflects this dynamism through its increasing focus on various emerging themes and trends. These trends highlight the advancements in oncology and the innovative approaches being adopted in clinical practice.
  1. Immunotherapy and Targeted Therapies:
    There is a significant rise in case reports documenting the use of immunotherapy and targeted therapies, showcasing their effectiveness and expanding the therapeutic options available to patients.
  2. Personalized Medicine:
    Emerging themes include case reports that focus on personalized treatment approaches based on genetic testing and molecular profiling, highlighting the shift towards tailored cancer therapy.
  3. Combination Therapies:
    The journal increasingly features reports on novel combination therapies, illustrating the trend towards integrating various treatment modalities for enhanced efficacy.
  4. Long-Term Follow-Up Studies:
    A growing number of submissions emphasize long-term follow-up and outcomes, reflecting the importance of understanding the durability of treatment responses and late effects.
  5. Real-World Evidence and Patient Experiences:
    There is a trend towards incorporating real-world evidence and patient-reported outcomes in case reports, providing insights into the practical implications of treatments in everyday clinical settings.

Declining or Waning

While the journal continues to thrive in several areas, certain themes have shown a declining interest in recent publications. This may reflect shifts in clinical practice, research focus, or the availability of newer methodologies.
  1. Traditional Chemotherapy Case Reports:
    There has been a noticeable decrease in case reports focusing solely on traditional chemotherapy treatments, as the oncology field increasingly emphasizes targeted therapies and immunotherapy.
  2. Standard Surgical Techniques:
    Case reports detailing standard surgical approaches without new insights or innovations are becoming less common, as the focus shifts towards minimally invasive procedures and novel surgical techniques.
  3. Palliative Care Cases:
    The frequency of case reports centered on palliative care alone has diminished, possibly due to a growing emphasis on curative and transformative therapies in oncology.
  4. Common Cancer Types:
    Reports on well-known malignancies, such as breast and lung cancer, without unique angles or significant clinical insights are less frequently submitted, indicating a preference for more complex or rare cases.
  5. Historical Treatment Comparisons:
    There is a decline in the publication of case reports comparing historical treatment regimens, as the field rapidly evolves and focuses on contemporary practices.

Similar Journals

Thoracic and Cardiovascular Surgeon Reports

Enhancing global visibility for pioneering surgical practices.
Publisher: GEORG THIEME VERLAG KGISSN: 2194-7635Frequency: 1 issue/year

Thoracic and Cardiovascular Surgeon Reports is a pivotal academic journal dedicated to the dissemination of innovative research and clinical practices in the fields of thoracic and cardiovascular surgery. Published by GEORG THIEME VERLAG KG, this journal has been an open-access publication since 2013, fostering a broader reach and enhancing visibility for authors and researchers globally. With its commitment to high-quality peer-reviewed articles, Thoracic and Cardiovascular Surgeon Reports serves as an essential platform for surgeons, clinicians, and scholars to share findings that advance medical knowledge, improve patient outcomes, and refine surgical techniques. The journal aims to bridge the gap between research and practical application, catering to an audience keen on staying updated with the latest in thoracic and cardiovascular interventions, making it a valuable resource in an ever-evolving medical landscape.

Case Reports in Gastrointestinal Medicine

Enhancing understanding of gastrointestinal complexities.
Publisher: HINDAWI LTDISSN: 2090-6528Frequency: 1 issue/year

Case Reports in Gastrointestinal Medicine, published by HINDAWI LTD, is a leading open-access journal dedicated to the dissemination of significant findings in the field of gastrointestinal medicine. Established in 2011, this journal champions the accessibility of scholarly work, allowing researchers, professionals, and students to explore vital case studies that enhance clinical understanding and patient care across various gastrointestinal conditions. With an emphasis on innovative practices and advances in treatment, the journal serves as an invaluable resource for those committed to furthering their knowledge and improving outcomes in gastrointestinal health. By promoting the robust sharing of case reports and clinical insights, Case Reports in Gastrointestinal Medicine not only contributes to the academic community but also supports practitioners in their quest for evidence-based practice.

BMJ Case Reports

Pioneering Clinical Excellence with Every Report
Publisher: BMJ PUBLISHING GROUPISSN: Frequency: 1 issue/year

BMJ Case Reports is a vital resource within the field of medicine, published by the esteemed BMJ PUBLISHING GROUP. With an E-ISSN of 1757-790X and a focus on disseminating high-quality case reports, this journal serves as a platform for healthcare professionals, researchers, and students to share unique clinical experiences and uncommon presentations of medical conditions. Since its inception in 2008 and continuing through 2024, it has gained recognition for contributing to the advancement of medical knowledge, currently ranking at Q4 in the Medicine (miscellaneous) category and positioned in the 54th percentile in General Medicine according to Scopus rankings. Although it is a subscription-based journal, its impact on clinical practice and education is significant, enabling practitioners to learn from diverse case studies and improving patient care outcomes. As it aims to enhance the understanding of rare and significant medical cases, BMJ Case Reports remains an essential publication for those at the forefront of medical innovation.

Journal of Kidney Cancer and VHL

Empowering research on kidney cancer and VHL.
Publisher: CODON PUBLICATIONSISSN: 2203-5826Frequency: 4 issues/year

The Journal of Kidney Cancer and VHL stands as a leading platform for disseminating cutting-edge research in the field of renal oncology, particularly focused on kidney cancer and Von Hippel-Lindau (VHL) disease. Published by CODON PUBLICATIONS since its inception, this Open Access journal, with ready accessibility since 2014, aims to foster knowledge exchange and collaboration among researchers, clinicians, and healthcare professionals dedicated to improving outcomes for patients with kidney cancer. With an ISSN of 2203-5826, this journal serves as a vital resource in the academic community, encouraging submissions that span various topics, including epidemiology, treatment modalities, and innovative therapeutic strategies. By providing unrestricted access to its content, the Journal of Kidney Cancer and VHL promotes inclusive participation in the global dialogue surrounding these critical health challenges, ensuring that the latest findings reach all corners of the scientific community.

Internal Medicine

Advancing the Frontiers of Internal Medicine
Publisher: JAPAN SOC INTERNAL MEDICINEISSN: 0918-2918Frequency: 12 issues/year

Internal Medicine is a distinguished peer-reviewed journal published by the Japan Society of Internal Medicine, focusing on the nuanced field of internal medicine. Since its inception in 1974 and with a commitment to advancing medical knowledge, the journal has evolved remarkably, aiming to disseminate high-quality research that contributes to the understanding and treatment of internal diseases. Operating from Tokyo, Japan, it provides an intellectual platform for researchers and clinicians to publish original articles, reviews, and case studies that address various aspects of internal medicine. The journal currently holds a ranking in the Q3 quartile for both Internal Medicine and miscellaneous Medicine categories as of 2023, signifying its growing influence in the medical community. Although not an open-access journal, it remains accessible to a wide audience through institutional subscriptions, enhancing its reach among professionals and students alike. With its commitment to excellence, Internal Medicine serves as an essential resource for those seeking the latest developments and research within this vital medical field.

ACG Case Reports Journal

Exploring the Frontiers of Gastroenterology One Case at a Time
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: Frequency: 12 issues/year

ACG Case Reports Journal, published by Lippincott Williams & Wilkins, is a pivotal resource in the realm of gastrointestinal medicine and clinical practice. Since its inception in 2014, this open-access journal has dedicated itself to disseminating high-quality case reports that contribute to the evolving understanding of gastrointestinal diseases and their management. With an impressive ranking of #203 out of 529 in the General Medicine category according to Scopus, placing it in the 61st percentile, the journal underscores its significant role in advancing medical knowledge. This accessibility allows researchers, healthcare professionals, and students to engage with groundbreaking case studies, enriching their expertise and promoting informed clinical decision-making. ACG Case Reports Journal aims to foster a collaborative environment where innovative ideas and clinical experiences converge, ultimately enhancing patient care and outcomes in the field of gastroenterology.

Hematology Reports

Advancing knowledge in blood disorders.
Publisher: MDPIISSN: 2038-8322Frequency: 4 issues/year

Hematology Reports is an esteemed academic journal in the field of hematology, dedicated to advancing the understanding of blood disorders and their treatment. Published by MDPI, a leading Swiss publisher known for its commitment to open access since 2009, this journal provides a valuable platform for researchers and healthcare professionals to disseminate innovative findings and foster collaboration within the academic community. The journal features an array of articles ranging from clinical studies to laboratory research, and is indexed in Scopus, where it currently holds a rank of 113 out of 137 in the Medicine - Hematology category, placing it in the 17th percentile. As an open-access journal, Hematology Reports ensures that critical research is accessible to a global audience, supporting the dissemination of knowledge that has the potential to improve patient outcomes. This journal is an essential resource for those engaged in the study and treatment of hematological conditions, encouraging dialogue and the exchange of ideas to enhance clinical practices.

CHEMOTHERAPY

Shaping the Future of Pharmacological Sciences
Publisher: KARGERISSN: 0009-3157Frequency: 4 issues/year

CHEMOTHERAPY, published by KARGER, is a premier academic journal established in 1960, dedicated to disseminating cutting-edge research and advancements in the fields of drug discovery, infectious diseases, oncology, and pharmacology. With an impressive Scopus ranking placing it in the Q2 category for major disciplines such as Drug Discovery and Infectious Diseases, this journal provides an invaluable platform for researchers and professionals aiming to explore new therapeutic approaches and methodologies. Located in the heart of Switzerland, its publications are a key resource for anyone looking to stay informed about the latest developments and trends in the pharmacological sciences. Researchers can benefit from its diverse scope while contributing to a growing body of knowledge that emphasizes the importance of effective chemotherapeutic strategies in modern medicine. Despite not being an Open Access journal, CHEMOTHERAPY remains committed to maintaining a rigorous peer-review process, ensuring the highest quality of published work.

Gastrointestinal Tumors

Innovating Insights into Gastrointestinal Health
Publisher: KARGERISSN: 2296-3774Frequency: 4 issues/year

Gastrointestinal Tumors is a reputable, peer-reviewed journal dedicated to advancing knowledge in the field of gastrointestinal oncology. Published by KARGER, this journal has been a pivotal platform since its transition to Open Access in 2014, ensuring that research findings are accessible to a global audience of researchers, clinicians, and students engaged in this vital area of study. With an emphasis on innovative research, clinical studies, and comprehensive reviews, Gastrointestinal Tumors aims to bridge gaps in knowledge and foster discussions that will inform and enhance clinical practices. The journal's commitment to excellence reflects the rising importance of gastrointestinal health in medical research, making it an essential resource for anyone seeking to stay at the forefront of this rapidly evolving field. Based in Basel, Switzerland, it is positioned within a strong academic community, and continues to influence the landscape of gastrointestinal cancer research.

Molecular and Clinical Oncology

Exploring new frontiers in molecular and clinical oncology.
Publisher: SPANDIDOS PUBL LTDISSN: 2049-9450Frequency: 12 issues/year

Molecular and Clinical Oncology is a dynamic journal published by SPANDIDOS PUBL LTD, aimed at advancing the understanding of cancer biology and treatment modalities. With an ISSN of 2049-9450 and an E-ISSN of 2049-9469, the journal serves as a critical platform for researchers and clinicians dedicated to uncovering novel insights in molecular oncology and enhancing clinical practices. As a testament to its growing influence, the journal has achieved a Q3 ranking in Oncology and a Q4 ranking in Cancer Research for the year 2023, reflecting its commitment to publishing high-quality research. Although currently not an Open Access publication, the journal offers crucial subscription options, ensuring comprehensive access to groundbreaking studies and innovations in the field. With converged years spanning 2018 to 2024, the journal is set to continue enriching the academic community with its valuable contributions, ultimately empowering researchers, professionals, and students engaged in the fight against cancer.